Vincent Medical Sets 2026 AGM to Approve Dividend, Board Mandates and Share Issue Authority

Vincent Medical Holdings Limited ( (HK:1612) ) has provided an announcement.

Vincent Medical Holdings has convened its annual general meeting for 20 May 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and vote on a proposed final dividend of HK2.6 cents per share. The agenda also includes re-election of board members across executive, non-executive and independent roles, authorisation for the board to set directors’ pay, and renewal of the mandate for RSM Hong Kong as auditor.

Investors will further be asked to approve a general mandate allowing the board to issue up to 20% of the company’s share capital, excluding treasury shares, with proportional adjustment in the event of any share consolidation or subdivision. The resolutions, if passed, will give management continued flexibility over capital raising and corporate actions while affirming existing governance arrangements, decisions that could shape Vincent Medical’s financing options and shareholder returns over the coming year.

More about Vincent Medical Holdings Limited

Vincent Medical Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the medical products sector. The company provides healthcare-related devices and solutions and is focused on serving hospital and clinical customers in its core Asian markets, leveraging its manufacturing base to support long-term growth and shareholder returns.

The group’s governance structure features a mix of executive, non-executive and independent non-executive directors, with oversight from an external auditor, and its shares are actively traded on the Main Board of the Stock Exchange of Hong Kong under stock code 1612.

Average Trading Volume: 811,543

Technical Sentiment Signal: Buy

Current Market Cap: HK$593.5M

For an in-depth examination of 1612 stock, go to TipRanks’ Overview page.